Innate Pharma (IPHA) Current Assets (2017 - 2026)
Innate Pharma (IPHA) reported Current Assets of $22.78 million for the quarter ended Jun 30, 2026, down 69.0% from $73.55 million a year earlier.
Powered by 
Analysis
Innate Pharma (IPHA) Current Assets (2017 - 2026) Analysis & Trends
As of Dec 31, 2025, Innate Pharma posted Current Assets of $52.77 million, down 43.1% from the prior year.
- Current Assets has a five-year compound annual growth rate of -23.2% (years ended Dec 2020 to Dec 2025).
- By year, Current Assets came in at $92.8 million in the year ended Dec 31, 2024 (-42.0%), $160.11 million in the year ended Dec 31, 2023 (+8.6%), $147.38 million in the year ended Dec 31, 2022 (-6.8%) and $158.16 million in the year ended Dec 31, 2021 (-20.1%).
- The figure for the quarter ended Jun 30, 2026 ranks as the lowest quarterly Current Assets in data going back to the quarter ended Dec 31, 2017.
- The high point for year-over-year Current Assets in five years was the quarter ended Jun 30, 2022 (growth of 17.4%); the low point was the quarter ended Jun 30, 2026 (a decline of 69.0%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 64.67 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 59.77 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 33.67 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 36.68 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 27.35 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 27.97 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 34.96 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 13.95 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 41.36 Bn |
| 10 | Innate Pharma | 143.35 Mn | -63.85 Mn | - | 22.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22.39 Mn |
| Dec 31, 2025 | 54.87 Mn |
| Jun 30, 2025 | 76.20 Mn |
| Dec 31, 2024 | 89.22 Mn |
| Jun 30, 2024 | 119.50 Mn |
| Dec 31, 2023 | 163.82 Mn |
| Jun 30, 2023 | 156.99 Mn |
| Dec 31, 2022 | 149.07 Mn |
| Jun 30, 2022 | 179.47 Mn |
| Dec 31, 2021 | 156.58 Mn |
| Jun 30, 2021 | 154.35 Mn |
| Dec 31, 2020 | 213.34 Mn |
| Jun 30, 2020 | 184.10 Mn |
| Dec 31, 2019 | 266.17 Mn |
| Dec 31, 2018 | 365.67 Mn |
| Dec 31, 2017 | 164.22 Mn |
API Access
Innate Pharma Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=IPHA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "IPHA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=IPHA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();